GB201410879D0 - Formulation with immuno-stimulant/adjuvant activity - Google Patents

Formulation with immuno-stimulant/adjuvant activity

Info

Publication number
GB201410879D0
GB201410879D0 GB201410879A GB201410879A GB201410879D0 GB 201410879 D0 GB201410879 D0 GB 201410879D0 GB 201410879 A GB201410879 A GB 201410879A GB 201410879 A GB201410879 A GB 201410879A GB 201410879 D0 GB201410879 D0 GB 201410879D0
Authority
GB
United Kingdom
Prior art keywords
stimulant
immuno
formulation
adjuvant activity
adjuvant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB201410879A
Other versions
GB2519828A (en
GB2519828B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad de Santiago de Chile
Original Assignee
Universidad de Santiago de Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad de Santiago de Chile filed Critical Universidad de Santiago de Chile
Publication of GB201410879D0 publication Critical patent/GB201410879D0/en
Publication of GB2519828A publication Critical patent/GB2519828A/en
Application granted granted Critical
Publication of GB2519828B publication Critical patent/GB2519828B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB1410879.9A 2013-06-18 2014-06-18 Formulation with immuno-stimulant/adjuvant activity Expired - Fee Related GB2519828B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2013001774A CL2013001774A1 (en) 2013-06-18 2013-06-18 Formulation with immunostimulant / adjuvant activity comprising alpinone, dimethyl sulfoxide and physiological serum; use of said formulation to prepare vaccines for vertebrates.

Publications (3)

Publication Number Publication Date
GB201410879D0 true GB201410879D0 (en) 2014-07-30
GB2519828A GB2519828A (en) 2015-05-06
GB2519828B GB2519828B (en) 2018-06-20

Family

ID=51266802

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1410879.9A Expired - Fee Related GB2519828B (en) 2013-06-18 2014-06-18 Formulation with immuno-stimulant/adjuvant activity

Country Status (4)

Country Link
CA (1) CA2854513A1 (en)
CL (1) CL2013001774A1 (en)
GB (1) GB2519828B (en)
NO (1) NO343949B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114748617A (en) * 2022-03-24 2022-07-15 华南农业大学 Subunit vaccine of micropterus salmoides iridovirus as well as preparation method and application thereof

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2013001774A1 (en) * 2013-06-18 2014-08-01 Univ Santiago Chile Formulation with immunostimulant / adjuvant activity comprising alpinone, dimethyl sulfoxide and physiological serum; use of said formulation to prepare vaccines for vertebrates.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL141627A0 (en) * 1998-08-24 2002-03-10 Maxim Pharm Inc Activation and protection of t-cells (cd4+and cd8+) using an h2 receptor agonist and other t-cell activating agents
BRPI1005670A8 (en) * 2009-01-05 2017-12-26 Epitogenesis Inc adjuvant compositions and processes of use.
CN103717235A (en) * 2011-06-24 2014-04-09 埃皮托吉尼西斯有限公司 Pharmaceutical compositions, comprising a combination of select carriers, vitamins, tannins and flavonoids as antigen-specific immuno-modulators
CL2013001774A1 (en) * 2013-06-18 2014-08-01 Univ Santiago Chile Formulation with immunostimulant / adjuvant activity comprising alpinone, dimethyl sulfoxide and physiological serum; use of said formulation to prepare vaccines for vertebrates.

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114748617A (en) * 2022-03-24 2022-07-15 华南农业大学 Subunit vaccine of micropterus salmoides iridovirus as well as preparation method and application thereof
CN114748617B (en) * 2022-03-24 2024-04-16 华南农业大学 Subunit vaccine of largemouth black bass iridovirus, and preparation method and application thereof

Also Published As

Publication number Publication date
NO20140763A1 (en) 2014-12-19
CL2013001774A1 (en) 2014-08-01
GB2519828A (en) 2015-05-06
NO343949B1 (en) 2019-07-22
GB2519828B (en) 2018-06-20
CA2854513A1 (en) 2014-12-18

Similar Documents

Publication Publication Date Title
HK1248138A1 (en) Imidazopyridine compounds and uses thereof
AU355185S (en) Chair
EP3065716C0 (en) Formulations
GB2508037B (en) Chair
EP2970924A4 (en) Phytase formulation
GB201319792D0 (en) Formulations
EP2961397A4 (en) Transdermal formulations
EP2951761A4 (en) Activity graphs
GB2520812B (en) Lift-recliner chair
HK1188365A2 (en) Activity center
EP3054972A4 (en) Vaccines with interleukin-33 as an adjuvant
GB201320432D0 (en) Novel formulation
HK1214951A1 (en) Ophthalimic formulations
HK1215411A1 (en) Takraw balls
AU351025S (en) Chair
SG11201505250UA (en) Chair massager
GB201322948D0 (en) Improved formulation
SG11201503793YA (en) Head massager
GB2519828B (en) Formulation with immuno-stimulant/adjuvant activity
GB2517232B (en) Formulation
GB201317718D0 (en) Novel formulation
GB201308122D0 (en) Chair
HK1209981A1 (en) Formulation
GB201312347D0 (en) Formulation
GB201317717D0 (en) Novel formulation

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20200618